Eli Lilly and Eisai's hopes of making their Alzheimer's disease therapies available to NHS patients in England have been knocked back, but the companies aren't going to take the decision lying down.
In its second guidance on digital health technologies within a week, NICE has endorsed five remote monitoring devices for patients with Parkinson’s disease that can be used to identify people who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results